Temporal muscle thickness is an independent prognostic marker in patients with progressive glioblastoma: translational imaging analysis of the EORTC 26101 trial

AbstractBackground. Temporal muscle thickness (TMT) was described as a surrogate marker of skeletal muscle mass. This study aimed to evaluate the prognostic re

Saved in:

Bibliographic Details
Main Authors:	Furtner-Srajer, Julia (Author) , Genbrugge, Els (Author) , Gorlia, Thierry (Author) , Bendszus, Martin (Author) , Nowosielski, Martha (Author) , Golfinopoulos, Vassilis (Author) , Weller, Michael (Author) , Van den Bent, Martin J. (Author) , Wick, Wolfgang (Author) , Preusser, Matthias (Author)
Format:	Article (Journal)
Language:	English
Published:	01 August 2019
In:	Neuro-Oncology Year: 2019, Volume: 21, Issue: 12, Pages: 1587-1594
ISSN:	1523-5866
DOI:	10.1093/neuonc/noz131
Online Access:	Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1093/neuonc/noz131 Verlag, lizenzpflichtig, Volltext: https://academic.oup.com/neuro-oncology/article/21/12/1587/5542781
Author Notes:	Julia Furtner, Els Genbrugge, Thierry Gorlia, Martin Bendszus, Martha Nowosielski, Vassilis Golfinopoulos, Michael Weller, Martin J. van den Bent, Wolfgang Wick, and Matthias Preusser

Description
Summary:	AbstractBackground. Temporal muscle thickness (TMT) was described as a surrogate marker of skeletal muscle mass. This study aimed to evaluate the prognostic re
Item Description:	Gesehen am 18.05.2020
Physical Description:	Online Resource
ISSN:	1523-5866
DOI:	10.1093/neuonc/noz131